SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

 

 

ACCRETIVE HEALTH, INC.

(Name of Issuer)

 

 

 

COMMON STOCK, $0.01 PAR VALUE PER SHARE

(Title of Class of Securities)

 

00438V 103

(CUSIP Number)

 

DECEMBER 31, 2010

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


   13G    Page 2 of 5 Pages

 

 

CUSIP No. 00438V 103

 

  1.   

NAMES OF REPORTING PERSONS:

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Ascension Health

31-1662309

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  ¨

 

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Missouri

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

SOLE VOTING POWER

 

    7,674,087

   6.   

SHARED VOTING POWER

 

   7.   

SOLE DISPOSITIVE POWER

 

    7,674,087

   8.   

SHARED DISPOSITIVE POWER

 

  9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    7,674,087

10.

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

    8.4%

12.

 

TYPE OF REPORTING PERSON

 

    CO

 


   13G    Page 3 of 5 Pages

 

CUSIP No. 00438V 103

 

Item 1   (a).    Name of Issuer:      
     Accretive Health, Inc.      
Item 1   (b).    Address of Issuer’s Principal Executive Offices:      
    

Accretive Health, Inc.

401 North Michigan Ave, Suite 2700

Chicago, IL 60611

     
Item 2   (a).    Name of Person Filing:      
     Ascension Health      
Item 2   (b).    Address of Principal Business Office or, if None, Residence:      
    

4600 Edmundson Road

St. Louis, MO 63134

     
Item 2   (c).    Citizenship:      
     Ascension Health is organized as a Missouri Non-profit Corporation      
Item 2   (d).    Title of Class of Securities:      
     Common Stock, $0.01 par value per share (the “Common Stock”)      
Item 2   (e).    CUSIP Number:      
     00438V 103      
Item 3.   If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:   
  (a)    ¨    Broker or dealer registered under Section 15 of the Act;
  (b)    ¨    Bank as defined in Section 3(a)(6) of the Act;
  (c)    ¨    Insurance company as defined in Section 3(a)(19) of the Act;
  (d)    ¨    Investment company registered under Section 8 of the Investment Company Act of 1940;
  (e)    ¨    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g)    ¨    A parent holding company or control person in accordance with §240.13d-1 (b)(1)(ii)(G);
  (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act;
  (j)    ¨    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
  (k)    ¨    Group, in accordance with §240.13d-1(b)(1)(ii)(K).
        Not Applicable.


   13G    Page 4 of 5 Pages

 

CUSIP No. 00438V 103

 

Item 4.    Ownership.      
   Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.      
   (a)    Amount beneficially owned: 7,674,087 shares of Common Stock      
   (b)    Percent of class: 8.4%      
   The foregoing percentage is calculated based on the 91,062,947 shares of Common Stock of Accretive Health, Inc. outstanding as of November 9, 2010 as reported in the issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 12, 2010.      
   (c)    Number of shares as to which such person has:      
      (i)    Sole power to vote or to direct the vote: 7,674,087      
      (ii)    Shared power to vote or to direct the vote: — 0 —      
      (iii)    Sole power to dispose or to direct the disposition of: 7,674,087      
      (iv)    Shared power to dispose or to direct the disposition of: — 0 —      
Item 5.    Ownership of Five Percent or Less of a Class.   
   Not Applicable.   
Item 6.    Ownership of More than Five Percent on Behalf of Another Person.      
   Not Applicable      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
   Not Applicable
Item 8.    Identification and Classification of Members of the Group.      
   Not Applicable      
Item 9.    Notice of Dissolution of Group.      
   Not Applicable      
Item 10.    Certification.      
   Not Applicable      


   13G    Page 5 of 5 Pages

 

CUSIP No. 00438V 103

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 10, 2011

 

/s/ Anthony J. Speranzo

Senior VP and Chief Financial Officer